EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • February 25th, 2010 • Viropharma Inc • Pharmaceutical preparations • New York
THIS EXCLUSIVE LICENSE AGREEMENT (this “Agreement”) dated as of February 20, 2006 (the “Effective Date”), is entered into between Dale N. Gerding, M.D., an individual (“Dr. Gerding”), and ViroPharma Incorporated, a Delaware corporation (“ViroPharma”).
MANUFACTURING AND DISTRIBUTION AGREEMENT (EUROPE AND ROW)Manufacturing and Distribution Agreement • February 25th, 2010 • Viropharma Inc • Pharmaceutical preparations
This Manufacturing and Distribution Agreement (Europe and ROW) (this “Agreement”) is made and entered into this 8th day of January, 2010 (the “Effective Date”), by and between Stichting Sanquin Bloedvoorziening (Sanquin Blood Supply Foundation), a foundation (stichting), incorporated under the laws of The Netherlands, with its registered seat in Amsterdam, and registered with the Trade Register of the Dutch Chamber of Commerce under number 41217565 (“Sanquin”), and ViroPharma SPRL, a private limited company organized under the laws of Belgium (“ViroPharma”) (each of Sanquin and ViroPharma is a “Party” and, collectively, they are the “Parties”).
Execution copy dated 8 January 2010Viropharma Inc • February 25th, 2010 • Pharmaceutical preparations
Confidential Treatment has been requested for portions of this exhibit. The copy filed herewith omits the information subject to the confidentiality request. Omissions are designated as “***”. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission.
